Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 05 Mar 2026 for Olema Pharmaceuticals, Inc., €56k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Shawnte Mitchell: trading record in brief
Filings by Shawnte Mitchell span 2 companies, the busiest being Olema Pharmaceuticals, Inc. and Zogenix, Inc. Between 7 March 2022 and 3 March 2026, the trades on record add up to 2 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 5 March 2026 came the latest disclosure, an option exercise for €56k in Olema Pharmaceuticals, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Shawnte Mitchell
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
15,000 shares@ US$4.37100.0% of flowCommon StockSEC:0001749432-26-000004:0
605 sharesCommon StockSEC:0000899243-22-010293:0
2 of 2 declarations
